Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuria
Brain · 2024
DOI: 10.1093/brain/awae139 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Brain, 2024. Verfasst von Raphaela Muri und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, …. Hauptthemen laut MEDLINE: Phenylketonurias, Phenylalanine, Magnetic Resonance Imaging, Brain. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation, Vontobel Foundation, Bangerter Rhyner Foundation.
Abstract (Originalsprache)
Phenylketonuria is a rare metabolic disease resulting from a deficiency of the enzyme phenylalanine hydroxylase. Recent cross-sectional evidence suggests that early-treated adults with phenylketonuria exhibit alterations in cortical grey matter compared to healthy peers. However, the effects of high phenylalanine exposure on brain structure in adulthood need to be further elucidated. In this double-blind, randomized, placebo-controlled crossover trial, we investigated the impact of a 4-week high phenylalanine exposure on the brain structure and its relationship to cognitive performance and metabolic parameters in early-treated adults with phenylketonuria. Twenty-eight adult patients with early-treated classical phenylketonuria (19–48 years) underwent magnetic resonance imaging before and after the 4-week phenylalanine and placebo interventions (four time points). Structural T1-weighted images were preprocessed and evaluated using Direct Cortical Thickness Estimation using Deep Learning-based Anatomy Segmentation and Cortex Parcellation (DL+DiReCT), a deep-learning-based tool for brain morphometric analysis. Cortical thickness, white matter volume and ventricular volume were compared between the phenylalanine and placebo periods. Brain phenylalanine levels were measured using 1H spectroscopy. Blood levels of phenylalanine, tyrosine, and tryptophan were assessed at each of the four time points, along with performance in executive functions and attention. Blood phenylalanine levels were significantly higher after the phenylalanine period (1441 µmol/l) than after the placebo period (873 µmol/l, P < 0.001). Morphometric analyses revealed a statistically significant decrease in cortical thickness in 17 of 60 brain regions after the phenylalanine period compared to placebo. The largest decreases were observed in the right pars orbitalis (point estimate = −0.095 mm, P < 0.001) and the left lingual gyrus (point estimate = −0.070 mm, P < 0.001). Bilateral white matter and ventricular volumes were significantly increased after the phenylalanine period. However, the structural alterations in the phenylalanine-placebo group returned to baseline measures following the washout and placebo period. Additionally, elevated blood and brain phenylalanine levels were related to increased bilateral white matter volume (rs = 0.43 to 0.51, P ≤ 0.036) and decreased cortical thickness [rs = −0.62 to −0.39, not surviving false discovery rate (FDR) correction] after the phenylalanine and placebo periods. Moreover, decreased cortical thickness was correlated with worse cognitive performance after both periods (rs = −0.54 to −0.40, not surviving FDR correction). These findings provide evidence that a 4-week high phenylalanine exposure in adults with phenylketonuria results in transient reductions of the cortical grey matter and increases in white matter volume. Further research is needed to determine the potential long-term impact of high phenylalanine levels on brain structure and function in adults with phenylketonuria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.
- Support Center for Advanced Neuroimaging (SCAN), University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.
- Translational Imaging Center (TIC), Swiss Institute for Translational and Entrepreneurial Medicine, 3010 Bern, Switzerland.
- Magnetic Resonance Methodology, Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.
- Division of Neuropaediatrics, Development and Rehabilitation, Department of Paediatrics, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.
ORCID-Profile: Michael Rebsamen, Roland Kreis, Regula Everts
Förderung
- Swiss National Science Foundation
- Vontobel Foundation
- Bangerter Rhyner Foundation
- Inselspital Bern
- Nutricia Metabolics Research Fund
- Fondation Rolf Gaillard pour la recherche en endocrinologie, diabétologie et métabolisme
- Swiss Foundation for Nutrition Research
Zitieren
APA
Muri, R., Rummel, C., McKinley, R., Rebsamen, M., Maissen-Abgottspon, S., Kreis, R., Radojewski, P., Pospieszny, K., Hochuli, M., Wiest, R., Trepp, R., & Everts, R. (2024). Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuria. Brain. https://doi.org/10.1093/brain/awae139
Vancouver
Muri R, Rummel C, McKinley R, Rebsamen M, Maissen-Abgottspon S, Kreis R, et al. Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuria. Brain. 2024. doi:10.1093/brain/awae139
BibTeX
@article{Muri2024,
author = {Muri, Raphaela and Rummel, Christian and McKinley, Richard and Rebsamen, Michael and Maissen-Abgottspon, Stephanie and Kreis, Roland and Radojewski, Piotr and Pospieszny, Katarzyna and Hochuli, Michel and Wiest, Roland and Trepp, Roman and Everts, Regula},
title = {Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuria},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae139}
}
EUVIMED